期刊文献+

一种制备质粒DNA的改良碱裂解法 被引量:3

A modified alkaline lysis method for extraction of plasmid DNA
下载PDF
导出
摘要 目的介绍一种快速获取高纯度质粒DNA的方法。方法使用替代试剂,建立改良的碱裂解法进行质粒DNA提取,并用琼脂糖电泳验证所得的质粒的质量,紫外测量估算产量及纯度。限制性酶切验证其用度。结果琼脂糖电泳显示质粒DNA条带明亮,以超螺旋方式为主。A260/280为1.903,含量为320μg/mL,酶切后得到约500bp的目的片段。结论改良碱裂解法操作简单、实用,所得样品纯度高,达到了分子生物学常规实验的要求。 [Objective] Introduce a method for rapid extraction of Superior-Quality Plasmid DNA. [Method] Use alternative reagent to establish modified alkaline lysis method for extraction of plasmid DNA and use agarose eleetrophoresis to examine the quality of plasmid DNA, ultraviolet speetrophotometry to evaluate its production and purity, restricted enzyme cutting to examine its availability. [Results] The agarose eleetrophoresis showed that the plasmid DNA band was bright, mainly by form of superhelix. A260/280 was 1.903, DNA concentration was 320μg/ ml, and we got 500 bp target fragment by restricted enzyme cutting. [Conclusion] We can get high purity of sample DNA by this simple and practical new method, it can meet the requirement of routine molecular biochemistry experiments.
出处 《中国医学工程》 2006年第2期199-201,共3页 China Medical Engineering
关键词 质粒 纯化 碱裂解法 plasmid purifing alkaline lysis
  • 相关文献

参考文献5

二级参考文献40

  • 1杨晓燕,朱道银.淋球菌质粒及其与耐药性关系的研究[J].中国皮肤性病学杂志,1997,11(3):135-137. 被引量:17
  • 2(美)J.萨姆布鲁克 E.F.弗里奇.分子克隆实验指南,第二版[M].北京:科学出版社,1995.24.
  • 3[1]Mulligan RC. The basic science of gene therapy [ J ]. Science,1993, 260: 926-932.
  • 4[2]Lew D, Parker SE, Latimer T, et al. Cancer gene therapy using plasmid DNA: Pharmacokimetic study of DNA following injection in mice (see abstract) [J]. Hum Gene Ther, 1995, 6: 553-564.
  • 5[3]Sakurai F, Nishioka T, Saito H, et al. Interaction between DNA cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous rout in mice: The role of the neutral helper lipid[J]. Gene Ther, 2001, 8: 677-686.
  • 6[4]Horton HM, Dorigo O, Hemandez P, et al. 1L-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor aseites and alters its eytokine profile[J]. J Immunol, 1999, 281: 78-81.
  • 7[5]Li S, Rizzo MA, Bhattaeharya S, Huang L. Characterization of cationic lipid-protamine-DNA ( LPD ) complexes for intravenous gene delivery[J]. Gene Ther, 1998, 5: 930-937.
  • 8[6]Li S, Tseng WC, Stolz DB, et al. Dynamic changes in the charac teristics of cationic lipidic vectors after exposure to mouse serum:Implication for intravenous lipofection[J]. Gene Ther, 1999, 6:585-594.
  • 9[7]Mahato RI, Anwer Khursheed, Tagliaferri Frank, et al. Biodistri butiom and gene expression of lipid/plasmid complexes after sys temic administration[J]. Hum Gene Ther, 1998, 9: 2083-2099.
  • 10[8]F Liu, H Qi, L Huang, et al. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous adminis tration[J]. Gene Ther, 1997, 4: 517-523.

共引文献24

同被引文献33

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部